Search for Clinical Trial Results

Sponsored By

Dumping Syndrome - 10 Studies Found

Status Study
Completed Study Name: Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
Condition: Dumping Syndrome
Date: 2012-05-09
Interventions: Drug: SOM230 Pasireotide (SOM230) sc injection was provided as solution for injection in individual 1-po
Completed Study Name: SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
Condition: Dumping Syndrome
Date: 2013-07-19
Interventions:
  • Drug: Lanreotide 90 mg slow release formulation

Completed Study Name: Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome
Condition: Postoperative Dumping Syndrome
Date: 2013-07-01
Interventions:
  • Drug: Pasireotide somatostatin
Completed Study Name: Treatment of the Dumping Syndrome With Lanreotide Autogel®
Condition: Dumping Syndrome
Date: 2007-10-11
Interventions: Drug: Somatuline (Lanreotide Autogel®)
Recruiting Study Name: Dumping Syndrome After Operation of Esophageal Atresia Type III
Condition:
  • Oesophageal Atresia
  • Dumping Syndrome

Date: 2015-08-14
Interventions: Biological: Oral Glucose 1.75g/kg of glucose is orally taken by the patient. Capillary glycemia is syste
Recruiting Study Name: Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity
Condition: Dumping Syndrome
Date: 2016-09-01
Interventions: Behavioral: Dietary and nutritional recommendations conducted by a nurse Supplementary dietary and nutri
Not yet recruiting Study Name: Gastrectomy, Eating Behaviour and GLP-1
Condition:
  • Gastric Cancer
  • Dumping Syndrome

Date: 2016-11-17
Interventions:
  • Other: Exendin 9-39 Complete b
Recruiting Study Name: Metabolic Consequences of Gastrointestinal Surgery
Condition:
  • Gastrectomy
  • Oesophagectomy
  • Dumping S
    Date: 2016-07-13
    Interventions:
    • Drug: Somatostatin Single dose
Recruiting Study Name: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Condition:
  • Cushing's Disease
  • Acromegaly
  • Neuroendocrine Tumors
    • Date: 2013-02-15
    Interventions: Drug: Pasireotide Pasireotide subcutaneous or Long Acting Release
Active, not recruiting Study Name: Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia
Condition: Hyperinsulinemia Hypoglycemia
Date: 2016-12-15
Interventions: Drug: Exendin (9-39)